Dealing In Aspen Securities
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen" or "the Company")
DEALING IN ASPEN SECURITIES
In compliance with the JSE Limited Listings Requirements, shareholders are advised of the following dealings
in Aspen's securities by a third-party intermediary ("the Intermediary").
A hedging transaction was entered into with the Intermediary to enable the Company to settle its future
obligation to employees participating in the SA Management Deferred Incentive Bonus Scheme ("the
Scheme") of Aspen and three of its wholly owned South African subsidiaries, namely Pharmacare Limited,
Aspen Finance (Pty) Limited and Fine Chemicals Corporation (Pty) Ltd. In terms of this hedging transaction
the Intermediary acquired Aspen shares as follows:
Date of transaction: 26 November 2024
Nature and details of transaction On-market purchase of securities to satisfy the future
by intermediary: obligations towards participants of the Scheme
Number of securities: 367 662
Purchase price: R169.00
Total value of the transaction: R62 134 878
Class of securities: Ordinary Shares
Nature of interest: Direct beneficial
Clearance obtained: Yes
Durban
28 November 2024
Sponsor:
Investec Bank Limited
Date: 28-11-2024 05:00:00
Supplied by www.sharenet.co.za
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.